Biomarker

Open Access
Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer
GABRIEL HENRIQUE CAXALI, LAÍZA BRUGNEROTTO, MIRIAN CAROLINI ESGOTI AAL, CAMILA FERREIRA BANNWART CASTRO and FLÁVIA KARINA DELELLA

Cancer Genomics & Proteomics September 2023, 20 (5) 487-499; DOI: https://doi.org/10.21873/cgp.20400
Open Access
OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus
DAI SHIMIZU, MITSURO KANDA, TAKAYOSHI KISHIDA, SHUNSUKE NAKAMURA, MASAHIRO SASAHARA, SEI UEDA, YUSUKE SATO, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, CHIE TANAKA, SATORU MOTOYAMA and YASUHIRO KODERA

Cancer Genomics & Proteomics July 2023, 20 (4) 343-353; DOI: https://doi.org/10.21873/cgp.20386
Open Access
A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer
ARTURAS DOBILAS, ANNA ÅKESSON, PIA LEANDERSSON and CHRISTER BORGFELDT

Cancer Genomics & Proteomics May 2023, 20 (3) 273-280; DOI: https://doi.org/10.21873/cgp.20380
Open Access
Transcriptomic Network Analysis Using Exfoliative Cervical Cells Could Discriminate a Potential Risk of Progression to Cancer in HPV-related Cervical Lesions: A Pilot Study
NORA JEE-YOUNG PARK, YESEUL CHOI, DONGHYEON LEE, JI YOUNG PARK, JONG MI KIM, YOON HEE LEE, DAE GY HONG, GUN OH CHONG and HYUNG SOO HAN

Cancer Genomics & Proteomics January 2023, 20 (1) 75-87; DOI: https://doi.org/10.21873/cgp.20366
Open Access
TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO

Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
Open Access
Protein Expression Profiling and Virtual Drug Screening as an Approach for Individualized Therapy of Small Cell Vaginal Carcinoma
MOHAMED E.M. SAEED, HASSAN E. KHALID, SAILESH K. THAKUR and THOMAS EFFERTH

Cancer Genomics & Proteomics July 2022, 19 (4) 512-525; DOI: https://doi.org/10.21873/cgp.20337
Open Access
Prognostic Relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc Finger Proteins in Clear Cell Renal Carcinoma
SIMONE O. HEYLIGER, KARAM F.A. SOLIMAN, MARILYN D. SAULSBURY and R. RENEE REAMS

Cancer Genomics & Proteomics May 2022, 19 (3) 305-327; DOI: https://doi.org/10.21873/cgp.20322
You have access
MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer
METTE PERNILLE MYKLEBUST, ANNE METTE SØVIKNES, OLE JOHAN HALVORSEN, ANNA THOR, OLAV DAHL and HELGE RÆDER

Cancer Genomics & Proteomics March 2022, 19 (2) 178-193; DOI: https://doi.org/10.21873/cgp.20313
You have access
CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
GWAN HEE HAN, JULIE KIM, HEE YUN, HANBYOUL CHO, JOON-YONG CHUNG, JAE-HOON KIM and STEPHEN M. HEWITT

Cancer Genomics & Proteomics November 2021, 18 (6) 699-713; DOI: https://doi.org/10.21873/cgp.20291
You have access
Salivary CCL20 Level as a Biomarker for Oral Squamous Cell Carcinoma
SEI UEDA, MITSUO GOTO, KENGO HASHIMOTO, SHOGO HASEGAWA, MASAHIKO IMAZAWA, MARICO TAKAHASHI, ICHIRO OH-IWA, KAZUO SHIMOZATO, TORU NAGAO and SHUJI NOMOTO

Cancer Genomics & Proteomics March 2021, 18 (2) 103-112; DOI: https://doi.org/10.21873/cgp.20245

Main menu

User menu

Search

Biomarker

Pages